BLISSGVS vs VENUSREM: Stock Comparison

BLISSGVS vs VENUSREMUpdated 2 Jul 26, 4:08 PM ISTNSE & company filings

BLISSGVS is the larger company by market capitalisation. BLISSGVS shows a higher net margin, while VENUSREM shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

BLISSGVS leads 4; VENUSREM leads 8 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

BLISSGVSVENUSREM

Valuation lens

What price are you paying?

Market CapContext only
₹7,127 Cr
₹2,233 Cr
P/E RatioVENUSREM has the lower reading
52.21x
19.22x ✓
P/B RatioVENUSREM has the lower reading
5.96x
3.36x ✓
EPSVENUSREM has the higher reading
₹4.72
₹19.1 ✓
Book ValueContext only
₹116.14
₹496.56
Dividend YieldVENUSREM has the higher reading
0.22%
0.56% ✓

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
BLISSGVS is the larger company
₹7,127 Cr vs ₹2,233 Cr
P/E Ratio
VENUSREM has a lower P/E
19.22x vs 52.21x
P/B Ratio
VENUSREM has a lower P/B
3.36x vs 5.96x
EPS
VENUSREM has higher earnings per share
₹19.1 vs ₹4.72
Dividend Yield
VENUSREM has a higher dividend yield
0.56% vs 0.22%
Revenue Growth (TTM YoY)
VENUSREM has faster revenue growth
33% vs 29.8%
EPS Growth (TTM YoY)
VENUSREM has faster EPS growth
126.4% vs 124.7%
Qtr Sales Growth
BLISSGVS has stronger quarterly sales growth
28.88% vs -0.03%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBLISSGVSVENUSREM
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricBLISSGVSVENUSREM
Live Price₹527.1₹1,796.7
Day Change0.68%0.03%
Volume3.93 L1.17 L
52-Week High₹553₹1,880
52-Week Low₹118₹432.1
Distance from 52W High-4.68%-4.43%

Valuation

MetricBLISSGVSVENUSREM
Market Cap₹7,127 Cr₹2,233 Cr
P/E Ratio52.21x19.22x
P/B Ratio5.96x3.36x
EPS₹4.72₹19.1
Book Value₹116.14₹496.56
Dividend Yield0.22%0.56%

Growth

MetricBLISSGVSVENUSREM
Revenue Growth (TTM YoY)29.8%33%
EPS Growth (TTM YoY)124.7%126.4%
Qtr Sales Growth28.88%-0.03%
Qtr Profit Growth33.03%11.14%

Profitability & Leverage

MetricBLISSGVSVENUSREM
ROE8.39%15.49%
ROCE9.22%16.2%
Net Margin13.93%13.35%
Operating Margin19.81%17.56%
Debt to Equity0x0x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricBLISSGVSVENUSREM
Promoter Holding35.01%▼ 0.35 pp41.76%
FII Holding8.07%▼ 2.38 pp2.92%▲ 0.12 pp
DII Holding9.47%▲ 4.43 pp0.89%▼ 0.31 pp
Public Holding47.45%▼ 1.7 pp54.43%▲ 0.19 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: BLISSGVS and VENUSREM.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.